Prof. Dr. Lothar Häberle

Department of Obstetrics and Gynaecology Medizinische Fakultät

Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) Guo Q, Burgess S, Turman C, Bolla MK, Wang Q, Lush M, Abraham J, et al. Journal article Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity (2017) Fasching P, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, et al. Journal article Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer (2017) Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Wiesmann da Silva Reis A, Schulz-Wendtland R, et al. Journal article Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods (2017) Häberle L, Hein A, Rübner M, Schneider M, Ekici AB, Gaß P, Hartmann A, et al. Journal article DasPAQT: Treating Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with Dasatinib - PCR-Monitoring, Adherence, Quality of Life, Therapy Satisfaction (OMC 2014-I; BMS CA180-565) (2016) Tesch H, Pelz H, Janssen J, Hansen R, Fietz T, Anhuf J, Häberle L, et al. Conference contribution DasPAQT: Treating patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with Dasatinib: PCR-Monitoring, adherence, quality of life, therapy satisfaction (OMC 2014-I; BMS CA180-565) - an analysis of the first 150 patients (2016) Tesch H, Pelz H, Janssen J, Hansen R, Fietz T, Anhuf J, Häberle L, et al. Conference contribution Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers (2016) Schmidt MK, Hogervorst F, Van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, et al. Journal article Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2016) Lei J, Rudolph A, Moysich KB, Behrens S, Goode EL, Bolla MK, Dennis J, et al. Journal article Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemacon A, Droit A, et al. Journal article Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial (2016) Schroeder L, Rack B, Sommer H, Koch JG, Weissenbacher T, Janni W, Schneeweiss A, et al. Journal article